Temporal and Spatial Compartmentalization of Drug-Resistant Cytomegalovirus (CMV) in a Child with CMV Meningoencephalitis: Implications for Sampling in Molecular Diagnosis

ABSTRACT We describe a case of antiviral-resistant cytomegalovirus meningoencephalitis occurring after hematopoietic stem cell transplantation. Antiviral-resistant cytomegalovirus was identified in blood 16 months earlier. However, wild-type cytomegalovirus was evidenced in blood when the meningoencephalitis was diagnosed. Treatment of meningoencephalitis should be adapted to all previously identified resistance mutations in any compartment.

[1]  S. Choi,et al.  Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient. , 2012, Diagnostic microbiology and infectious disease.

[2]  R. Fanin,et al.  Late onset cytomegalovirus encephalitis after reduced-intensity conditioning allogeneic SCT: an emerging neurological complication? , 2011, Bone Marrow Transplantation.

[3]  S. Chou,et al.  Antiviral Drug Resistance of Human Cytomegalovirus , 2010, Clinical Microbiology Reviews.

[4]  M. Territo,et al.  CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency , 2010, Bone Marrow Transplantation.

[5]  P. Hubáček,et al.  Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet , 2009, Pediatric transplantation.

[6]  H. Agut,et al.  Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection. , 2009, Antiviral research.

[7]  M. Battiwalla,et al.  Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  A. Kassim,et al.  Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Chou,et al.  How Evolution of Mutations Conferring Drug Resistance Affects Viral Dynamics and Clinical Outcomes of Cytomegalovirus-Infected Hematopoietic Cell Transplant Recipients , 2005, Journal of Clinical Microbiology.

[10]  D. Witte,et al.  Emergence and Compartmentalization of Fatal Multi-Drug-Resistant Cytomegalovirus Infection in a Patient With Autosomal-Recessive Severe Combined Immune Deficiency , 2004, Journal of pediatric hematology/oncology.

[11]  C. Mengelle,et al.  Detection of ganciclovir resistance after valacyclovir‐prophylaxis in renal transplant recipients with active cytomegalovirus infection , 2004, Journal of medical virology.

[12]  D. Wolf,et al.  Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. , 2003, Blood.

[13]  H. Balfour,et al.  Ganciclovir‐resistant cytomegalovirus encephalitis in a bone marrow transplant recipient , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[14]  S. Seo,et al.  Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Michel,et al.  Aciclovir selects for ganciclovir‐cross‐resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein * , 2001, Journal of medical virology.

[16]  H. Balfour,et al.  Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. , 1998, The Journal of infectious diseases.

[17]  F. Hufert,et al.  Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation , 2004, Bone Marrow Transplantation.

[18]  H. Einsele,et al.  Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain. , 2003 .